Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2023-09-11 Purchase | 2023-09-13 08:43 am | Sensei Biotherapeutics Inc. | SNSE | Celebi John President and CEO | 500 | $0.85 | $425 | 111,311 (Direct) | View |
2023-06-01 Sale | 2023-06-02 5:03 pm | Sensei Biotherapeutics Inc. | SNSE | Apeiron Investment Group Ltd. Angermayer Christian Presight Sensei Co-Invest Fund L.P. Presight Co-Invest Management L.L.C. 10% Owner | 3,441,661 | $1.58 | $5,437,824 | 0 (Indirect) | View |
2023-02-23 Purchase | 2023-02-27 8:10 pm | Sensei Biotherapeutics Inc. | SNSE | Apeiron Investment Group Ltd. Angermayer Christian Presight Sensei Co-Invest Fund L.P. Presight Co-Invest Management L.L.C. 10% Owner | 2,200 | $1.6086 | $3,539 | 3,441,661 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2024-09-26 4:36 pm | N/A 2034-07-30 | Sensei Biotherapeutics Inc. | SNSE | Craver Josiah Principal Financial Officer | 0 | $0 | 80,000 (Direct) | View |
2024-06-11 Option Award | 2024-06-13 5:11 pm | N/A 2034-06-10 | Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner | 19,000 | $0 | 19,000 (Direct) | View |
2024-06-11 Option Award | 2024-06-13 5:10 pm | N/A 2034-06-10 | Sensei Biotherapeutics Inc. | SNSE | Peyer James Director 10% Owner | 19,000 | $0 | 19,000 (Indirect) | View |
2024-06-11 Option Award | 2024-06-13 5:08 pm | N/A 2034-06-10 | Sensei Biotherapeutics Inc. | SNSE | Holmen Bob Director | 19,000 | $0 | 19,000 (Direct) | View |
2024-06-11 Option Award | 2024-06-13 5:07 pm | N/A 2034-06-10 | Sensei Biotherapeutics Inc. | SNSE | English Jessie Director | 19,000 | $0 | 19,000 (Direct) | View |
2024-06-11 Option Award | 2024-06-13 5:06 pm | N/A 2034-06-10 | Sensei Biotherapeutics Inc. | SNSE | Humer Kristian Director | 19,000 | $0 | 19,000 (Direct) | View |
2024-06-11 Option Award | 2024-06-13 5:04 pm | N/A 2034-06-10 | Sensei Biotherapeutics Inc. | SNSE | RINGO WILLIAM R Director | 19,000 | $0 | 19,000 (Direct) | View |
2024-06-11 Option Award | 2024-06-13 5:03 pm | N/A 2034-06-10 | Sensei Biotherapeutics Inc. | SNSE | RICKS THOMAS G Director | 19,000 | $0 | 19,000 (Direct) | View |
2024-06-11 Option Award | 2024-06-13 5:01 pm | N/A 2034-06-10 | Sensei Biotherapeutics Inc. | SNSE | Vojta Deneen Director | 19,000 | $0 | 19,000 (Direct) | View |
2024-02-15 Tax Withholding | 2024-02-16 6:37 pm | N/A N/A | Sensei Biotherapeutics Inc. | SNSE | van der Horst Edward CHIEF SCIENTIFIC OFFICER | 2,843 | $0.79 | 271,172 (Direct) | View |
2024-02-15 Option Award | 2024-02-16 6:37 pm | N/A 2034-02-14 | Sensei Biotherapeutics Inc. | SNSE | van der Horst Edward CHIEF SCIENTIFIC OFFICER | 215,102 | $0 | 271,172 (Direct) | View |
2024-02-15 Tax Withholding | 2024-02-16 6:28 pm | N/A N/A | Sensei Biotherapeutics Inc. | SNSE | Celebi John PRESIDENT AND CEO | 5,891 | $0.79 | 586,309 (Direct) | View |
2024-02-15 Option Award | 2024-02-16 6:28 pm | N/A 2034-02-14 | Sensei Biotherapeutics Inc. | SNSE | Celebi John PRESIDENT AND CEO | 480,889 | $0 | 586,309 (Direct) | View |
2024-02-15 Tax Withholding | 2024-02-16 6:25 pm | N/A N/A | Sensei Biotherapeutics Inc. | SNSE | Colgan Erin CHIEF FINANCIAL OFFICER | 3,627 | $0.79 | 286,590 (Direct) | View |
2024-02-15 Option Award | 2024-02-16 6:25 pm | N/A 2034-02-14 | Sensei Biotherapeutics Inc. | SNSE | Colgan Erin CHIEF FINANCIAL OFFICER | 219,128 | $0 | 286,590 (Direct) | View |
2023-11-01 Option Award | 2023-11-02 4:53 pm | N/A 2033-10-31 | Sensei Biotherapeutics Inc. | SNSE | Krebs Stephanie Chief Business Officer | 125,000 | $0 | 125,000 (Direct) | View |
2023-02-15 Tax Withholding | 2023-09-11 5:34 pm | N/A N/A | Sensei Biotherapeutics Inc. | SNSE | Gallagher Patrick Stephen Chief Business Officer | 9,383 | $1.5 | 34,130 (Direct) | View |
2023-02-15 Tax Withholding | 2023-09-11 5:33 pm | N/A N/A | Sensei Biotherapeutics Inc. | SNSE | van der Horst Edward Chief Scientific Officer | 9,525 | $1.5 | 52,913 (Direct) | View |
2023-02-15 Tax Withholding | 2023-09-11 5:33 pm | N/A N/A | Sensei Biotherapeutics Inc. | SNSE | Celebi John President and CEO | 20,492 | $1.5 | 110,811 (Direct) | View |
2023-02-15 Tax Withholding | 2023-09-11 5:31 pm | N/A N/A | Sensei Biotherapeutics Inc. | SNSE | Colgan Erin Chief Financial Officer | 10,943 | $1.5 | 68,089 (Direct) | View |
2023-07-31 Disposition | 2023-08-02 5:09 pm | N/A N/A | Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc See Remarks 10% Owner | 1,587,302 | $1.26 | 3,653,120 (Direct) | View |
2023-07-31 Disposition | 2023-08-02 5:06 pm | N/A N/A | Sensei Biotherapeutics Inc. | SNSE | Peyer James Director 10% Owner | 1,587,302 | $1.26 | 3,653,120 (Indirect) | View |
2023-07-10 Option Award | 2023-07-12 5:03 pm | N/A 2033-07-09 | Sensei Biotherapeutics Inc. | SNSE | RINGO WILLIAM R Director | 19,016 | $0 | 37,949 (Direct) | View |
2023-07-10 Option Award | 2023-07-12 5:02 pm | N/A 2033-07-09 | Sensei Biotherapeutics Inc. | SNSE | RICKS THOMAS G Director | 19,016 | $0 | 358,413 (Direct) | View |
2023-07-10 Option Award | 2023-07-12 5:00 pm | N/A 2033-07-09 | Sensei Biotherapeutics Inc. | SNSE | Broder Samuel Director | 19,016 | $0 | 23,482 (Direct) | View |
2023-07-10 Option Award | 2023-07-12 4:50 pm | N/A 2033-07-09 | Sensei Biotherapeutics Inc. | SNSE | Humer Kristian Director | 19,016 | $0 | 23,482 (Direct) | View |
2023-07-10 Option Award | 2023-07-12 4:48 pm | N/A 2033-07-09 | Sensei Biotherapeutics Inc. | SNSE | English Jessie Director | 19,016 | $0 | 23,482 (Direct) | View |
2023-07-10 Option Award | 2023-07-12 4:46 pm | N/A 2033-07-09 | Sensei Biotherapeutics Inc. | SNSE | Vojta Deneen Director | 19,016 | $0 | 23,482 (Direct) | View |
2023-07-10 Option Award | 2023-07-12 4:44 pm | N/A 2033-07-09 | Sensei Biotherapeutics Inc. | SNSE | Holmen Bob Director | 19,016 | $0 | 40,148 (Direct) | View |
2023-07-10 Option Award | 2023-07-12 4:29 pm | N/A 2033-07-09 | Sensei Biotherapeutics Inc. | SNSE | Peyer James Director 10% Owner | 19,016 | $0 | 5,254,972 (Indirect) | View |
2023-07-10 Option Award | 2023-07-12 4:27 pm | N/A 2033-07-09 | Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner | 19,016 | $0 | 5,254,972 (Direct) | View |
2023-02-15 Option Award(A) | 2023-03-29 5:17 pm | N/A 2033-02-14 | Sensei Biotherapeutics Inc. | SNSE | Colgan Erin Chief Financial Officer | 141,346 | $0 | 169,032 (Direct) | View |
2023-02-15 Option Award(A) | 2023-03-29 5:16 pm | N/A 2033-02-14 | Sensei Biotherapeutics Inc. | SNSE | Celebi John President and CEO | 163,193 | $0 | 221,303 (Direct) | View |
2023-02-15 Option Award(A) | 2023-03-29 5:13 pm | N/A 2023-02-14 | Sensei Biotherapeutics Inc. | SNSE | Gallagher Patrick Stephen Chief Business Officer | 103,513 | $0 | 103,513 (Direct) | View |
2022-06-10 Option Award(A) | 2023-03-07 5:15 pm | N/A 2032-06-09 | Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner | 19,016 | $0 | 5,250,506 (Direct) | View |
2023-02-15 Option Award | 2023-02-17 5:01 pm | N/A 2033-02-14 | Sensei Biotherapeutics Inc. | SNSE | van der Horst Edward Chief Scientific Officer | 116,265 | $0 | 137,438 (Direct) | View |
2023-02-15 Option Award | 2023-02-17 5:01 pm | N/A 2023-02-14 | Sensei Biotherapeutics Inc. | SNSE | Gallagher Patrick Stephen Chief Business Officer | 103,513 | $0 | 103,515 (Direct) | View |
2023-02-15 Option Award | 2023-02-17 5:01 pm | N/A 2033-02-14 | Sensei Biotherapeutics Inc. | SNSE | Colgan Erin Chief Financial Officer | 141,346 | $0 | 163,032 (Direct) | View |